In recent years, various studies have supported the anti-tumor effects of cannabinoids (1). Cannabidiol or CBD, which has no psychoactive effect, would be a powerful remedy for various cancers. We list them for you.
The clinical use of tetrahydrocannabinol (THC) is often limited by their undesirable psychoactive side effects. The interest in non-psychoactive cannabinoid compounds, such as cannabidiol (CBD), has increased considerably in recent years. Studies emphasize the efficacy of CBD in various stages of tumorigenesis in various cancers (2). Cancer cells die while normal cells remain unaffected. These findings indicate that CBD is a promising alternative therapeutic agent. A number of cancers where CBD can be effective according to various studies:
Pancreatic cancer is one of the most deadly forms of cancer worldwide, because the survival rate is so low. Research has shown that mice with pancreatic cancer lived nearly three times as long as they had CBD than those treated with chemotherapy alone. Read our article about CBD and pancreatic cancer here for more information.
Another study shows that CBD could stop cell growth in various cervical cancer cell lines (cervical cancer cells). Read the article about CBD and cervical cancer here at What’s Behind The Dots.
Another study shows the efficacy of CBD in breast cancer. CBD inhibits the growth of aggressive human breast cancer cells. It significantly reduces the primary tumor mass as well as the metastases (3).
Prostate cancer is a global public health problem and the second cause of cancer death. Research shows that prostate cancer cells have type 1 and 2 cannabinoid receptors and stimulation results in a decrease in the viability of the cancer cells and increased apoptosis (cell death). (4)
Another study found that cannabinoids suppress the invasion of cancer cells in lung cancer patients (5).
THC and other cannabinoids also inhibit brain tumor growth. The patients had previously failed in standard therapy (surgery and radiotherapy) and had clear evidence of tumor progression. Cannabinoid release was safe and could be achieved without clear psychoactive effects. THC inhibited cancer cell growth in two out of nine patients (6).